Geriatric Psychiatry
RSS
News of Note: Donanemab Gains FDA Approval for Early Alzheimer’s Treatment
Stephanie Collier, MD and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material.
High-Dose Aspirin and Age Are the Only Convincing Depression Risk Factors in Late Life
Kathryn Kieran, MSN, PMHNP-BC. Ms. Kieran has no financial relationships with companies related to this material.
Moderate Alcohol Use and Cognitive Decline
Kathryn Kieran, MSN, PMHNP-BC. Ms. Kieran has no financial relationships with companies related to this material.
Considerations in Prescribing Lithium in Older Adults
Shireen Wissa, PharmD Candidate 2025. Keck Graduate Institute School of Pharmacy, Claremont, CA.
Talia Puzantian, PharmD, BCPP. Keck Graduate Institute School of Pharmacy, Claremont, CA.
Ms. Wissa and Dr. Puzantian have no financial relationships with companies related to this material.
Reevaluating Diagnosis Criteria for Minoritized Populations
Carmen G. Black, MD, MHS
Vice Chair of Education, Institute of Living at Hartford Hospital; Adjunct Assistant Professor of Psychiatry, Yale School of Medicine, New Haven, CT.
Dr. Black has no financial relationships with companies related to this material.
Disparities in Dementia Diagnosis
Nicolás Pérez Palmer, MD
Assistant Professor of Psychiatry, Yale School of Medicine, New Haven, CT; Director of Clinical Research Services, Latino Community, Alzheimer’s Disease Research Unit; Integrated Firm Director, Psychiatry, VA Connecticut Healthcare System.
Dr. Pérez Palmer has no financial relationships with companies related to this material.
How to Talk to Patients About Ageism and Racism
Carmen G. Black, MD, MHS. Vice Chair of Education, Institute of Living at Hartford Hospital; Adjunct Assistant Professor of Psychiatry, Yale School of Medicine, New Haven, CT.
Dr. Black has no financial relationships with companies related to this material.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
